Breaking News

Terumo BCT Expands Automation Offerings in Latin America

Supports the adoption of automation to help CGT companies scale their manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, is expanding its offerings in Latin America to help bring automated manufacturing to cell and gene therapy companies in Brazil, Colombia and Mexico.   Terumo BCT, with a focus on automation, makes products that collect, process and separate blood and cells, along with automated manufacturing platforms that support cell and gene therapy (CGT) developers.   “Across the cell and gene therapy sector, Terumo BCT is sup...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters